zlacker

>>giulio+(OP)
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024.

I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US.

In my friend circle in Germany I don't even know one single person on this stuff.

It's insane to me that so many people need these to get off the processed foods killing them in the US.

>>carlmr+B5
in europe there is a social stigma around GLP-1 drugs, a lot of people considered it cheating and lazy, so a lot of people don't dare talk about their usage

>>Raed66+e6
The social stigma in Europe exists, because these drugs are in limited supply. So, if a person who does not really need them is using them, the people who actually need them to stay alive might have difficulty accessing them.

>>Foivos+E7
> because these drugs are in limited supply

That's the first time I hear about this. A close friend of mine uses it and she just goes to the pharmacy. Never heard about any problems with supply.

>>Mashim+v9
Where is that? I'm pretty sure in France you can't just walk into a pharmacy and buy it, you need a prescription.

>>vladva+Kd
Yes, she has a prescription. I did not think it was relevant to the supply.

>>Mashim+Tj
I think it's somewhat related. The French social security site has a page asking phamacists to make sure the prescriptions are correct, in order to guarantee availability to people who actually need this [0].

This sounds pretty much like the supply is somewhat limited for whatever reason.

---

[0] https://www.ameli.fr/pharmacien/actualites/antidiabetiques-a...

>>vladva+Fo
That is nearly a year old now.

There were previously supply issues with these drugs throughout Europe, but those were mostly resolved by the end of 2024.

By mid-2025, it was (and still is) possible to easily get all of the medicines for any of the approved uses, including weight loss and diabetes.